ArticleFrontiers in medicine2020

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.

Ammon Handisurya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.